Text Size

Screening Brief Intervention Referral to Treatment (SBIRT) in New Mexico

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Friends Research Institute, Inc.
ClinicalTrials.gov Identifier:
NCT01131520
First received: May 21, 2010
Last updated: November 30, 2012
Last verified: November 2012
History of Changes
  Purpose

The purpose of this study is to compare the effectiveness in reducing drug use and its associated problems of a brief intervention for drug use delivered by a behavioral health counselor as compared to a brief intervention delivered by a computerized intervention.


Condition Intervention
Drug Abuse
HIV Risk Behavior
 Behavioral: Computerized brief intervention
Behavioral: Counselor delivered brief intervention

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: SBIRT in New Mexico

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Friends Research Institute, Inc.:

Primary Outcome Measures:
  • Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score [ Time Frame: 3 months post-baseline ] [ Designated as safety issue: No ]
  • Radioimmunoassay (RIA)Hair Testing for opiates, cocaine, amphetamine and tetrahydrocannabinol (THC) [ Time Frame: 3 month post-baseline ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Human Immunodeficiency Virus (HIV) Risk Behavior [ Time Frame: 3 months post-baseline ] [ Designated as safety issue: No ]
  • Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score [ Time Frame: 6 month post-baseline ] [ Designated as safety issue: No ]
  • Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score [ Time Frame: 12 months post-baseline ] [ Designated as safety issue: No ]
  • Radioimmunoassay (RIA)Hair Testing for opiates, cocaine, amphetamine and tetrahydrocannabinol (THC) [ Time Frame: 6 month post-baseline ] [ Designated as safety issue: No ]
  • Radioimmunoassay (RIA)Hair Testing for opiates, cocaine, amphetamine and THC [ Time Frame: 12 month post-baseline ] [ Designated as safety issue: No ]
  • Human Immunodeficiency Virus (HIV) Risk Behavior [ Time Frame: 6 month post-baseline ] [ Designated as safety issue: No ]
  • Human Immunodeficiency Virus (HIV) Risk Behavior [ Time Frame: 12 month post-baseline ] [ Designated as safety issue: No ]

Estimated Enrollment: 360
Study Start Date: June 2010
Estimated Study Completion Date: July 2014
Estimated Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Computerized Brief Intervention
Computerized one-session brief intervention for drug use
 Behavioral: Computerized brief intervention
This is a brief computerized intervention focused on drug use of patients receiving primary care treatment in an outpatient setting. The intervention is delivered in one session.
Active Comparator: Counselor delivered brief intervention
This is a brief intervention focused on drug use delivered by a behavioral health counselor and based on motivational interviewing
 Behavioral: Counselor delivered brief intervention
This is a one session brief intervention delivered in a primary care setting that is based on motivational interviewing.

Detailed Description:

Drug use is a significant cause of morbidity and mortality in the United States. Efforts to develop and rigorously evaluate methods to provide Screening, Brief Intervention and Referral to Treatment (SBIRT) for drug users are needed. Computerized screening and brief interventions in particular have the potential to circumvent some of the potential problems of integrating SBIRT delivered by a counselor into busy primary care settings. These interventions may reduce drug use among individuals who are using drugs but are not yet drug dependent.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18 years or older
  • Moderate risk category on the ASSIST scores

Exclusion Criteria:

  • planning to move out of New Mexico in the next year
  • receipt of formal drug abuse treatment or a brief intervention for drug use in the past month.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01131520

Locations
United States, Maryland
Friends Research Institute
Baltimore, Maryland, United States, 21201
Sponsors and Collaborators
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Robert P Schwartz, M.D. Friends Research Institute, Inc.
  More Information

No publications provided

Responsible Party: Friends Research Institute, Inc.
ClinicalTrials.gov Identifier: NCT01131520     History of Changes
Other Study ID Numbers: 08-08-173, R01DA026003
Study First Received: May 21, 2010
Last Updated: November 30, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Friends Research Institute, Inc.:
SBIRT
Drug abuse

Additional relevant MeSH terms:
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 19, 2013